High-Throughput Screening (HTS) Market: Qualitative Analysis, Quantitative Analysis, Forecast up to 2030

SDKI Inc. published a new report on the High-Throughput Screening (HTS) Market-Global Forecast 2023. This study includes the statistical and analytical approaches needed to grow the high-throughput screening market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-109707

The HTS market is estimated to grow from US $ 14.87 billion in 2018 to US $ 21.69 billion by 2023, with a CAGR of 7.8%. Initiatives by pharmaceutical and biotechnology companies, increased R & D spending and HTS technology development are expected to contribute to market growth. In addition, the availability of government funding and venture capital investment is also a driver of growth in the HTS market.

Market Segments

The high-throughput screening market is by technology (cell-based assays, lab-on-chips, bioinformatics), applications (target identification, primary screening, toxicology), products (reagents, equipment, software, services), end users. It is divided by region and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Report sample URL
https://www.sdki.jp/sample-request-109707

The software segment is expected to register the largest CAGR during the forecast period.

Based on products and services, the HTS market is divided into reagents and assay kits, equipment, consumables and accessories, software, and services. The software segment is expected to register the largest CAGR during the forecast period. Increased automation of high-throughput screening and the availability of robust data management software tools are key factors contributing to the growth of this segment. This allows researchers to develop a systematic and process-oriented approach to HTS technology.

The Contract Research Organization (CRO) segment is expected to grow at the fastest rate during the forecast period.

Based on end users, the HTS market is divided into pharmaceutical and biotechnology companies, academic and government agencies, contract research organizations (CROs), and other end users (hospital and food, agricultural and environmental industries). The outsourced research institute segment is expected to register the largest CAGR during the forecast period due to increased outsourcing of HTS services by many pharmaceutical and biotechnology companies.

Regional Overview

The high-throughput screening market is further subdivided based on region and is evaluated for market growth in each country. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, United Kingdom, and other Europe), Asia Pacific (China, Japan, India, Australia, and other Asia Pacific). ) And other regions.

North America had the largest share of the global HTS market in 2017. Meanwhile, the Asia Pacific region is expected to witness a significant CAGR during the forecast period. This growth is due to higher R & D spending, increased trends in drug discovery services outsourcing, expanded public-private partnerships, and increased government funding in the region.

Detailed contents of the survey report
https://www.sdki.jp/reports/high-throughput-screening-market/109707

Major key players:

Key players in the high-throughput screening market include Agilent (USA), Danaher (USA), Thermo Fisher Scientific (USA), PerkinElmer (USA), Tecan (Switzerland), Axxam (Italy), Merck Group (Germany), These include Bio-Rad (USA), Hamilton (USA), Corning (USA), BioTek (USA), Aurora Biomed (Canada). The study includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these key companies in the high-throughput screening market.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.